0

Imatinib-d8

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAPS1092942829
CAS1092942-82-9
SynonymsImatinib-d8, 4-[(4-Methyl-1-piperazinyl-d8)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, 4-(2,2,3,3,5,5,6,6-Octadeuterio-4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide, Imatinib-D8 (piperazinyl-D8),Benzamide, 4-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, 4-[(4-Methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, Genfatinib-d8
IUPAC NameN-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[(2,2,3,3,5,5,6,6-octadeuterio-4-methylpiperazin-1-yl)methyl]benzamide
Molecular Weight501.65
Molecular FormulaC292H8H23N7O
Canonical SMILES[2H]C1([2H])N(C)C([2H])([2H])C([2H])([2H])N(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)C1([2H])[2H]
InChIInChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)/i14D2,15D2,16D2,17D2
Accurate Mass501.3092
FormatNeat
Product TypeStable Isotope Labelled
  • Verification code
CATSizeShippingStorage ConditionsDescription
APS1092942829-10MG 10MG Room Temperature 2-8°C Fridge/Coldroom Subcategory: Stable isotope labelled compounds, Enzyme inhibitors, Abl kinase inhibitors Inquiry
APS1092942829-1MG 1MG Room Temperature 2-8°C Fridge/Coldroom Subcategory: Enzyme inhibitors, Abl kinase inhibitors, Stable isotope labelled compounds, Pharmaceutical Inquiry
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode
Privacy Policy | Cookie Policy | Copyright © 2024 Alfa Chemistry. All rights reserved.